Groowe Groowe / Newsroom / BMY
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

BMY News

Bristol-Myers Squibb Co.

Immune Checkpoint Inhibitor Therapy May Reduce Asthma Exacerbations

prnewswire.com
MRK BMY

World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors

prnewswire.com
GILD AZN BMY ABBV

BCL-2 Inhibitors Market Poised for Robust Growth During the Forecast Period (2025-2034) as Oncology Pipelines Expand | DelveInsight

prnewswire.com
ABBV AMGN AZN BMY GILD JNJ LLY MRK NVS PFE SNY TMO

BioNJ Elects Board Officers and Trustees

prnewswire.com
GMAB MRK AMTX JNJ ASND ACAD BMY PFE PTC NVS SNY CLDX

Alzheimer's Therapeutics Market to Reach USD 10.4 Billion by 2036 as Disease-Modifying Immunotherapies Transform Treatment Paradigms

accessnewswire.com
ABBV BMY JNJ LLY NVS REGN BIIB

ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS

globenewswire.com
ATAI JNJ BMY NVS

ACROBiosystems stimule l'innovation au cours du JPM Spotlight de bioSeedin, en soutenant stratégiquement l'établissement de partenariats mondiaux USA - Français USA - English USA - español USA - Deutsch

prnewswire.com
PFE LLY ABBV GSK BMY

EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

prnewswire.com
AVBP SMMT MRUS MRK GNPX CGEM ABBV BMY BDTX LTRN PFE JNJ LLY

Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award

accessnewswire.com
BMY

Molecule Found to Drive Skin Cancer Growth and Evade Immune Detection

prnewswire.com
BMY MRK